Serial #79427929
LIVE

Serial Number

79427929

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Apr 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79427929 Trademark

Serial Number: 79427929 • Registration: 8122738

Serial #79427929 is a trademark filed by Novartis AG on April 23, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

April 23, 2025

Registration Date

February 3, 2026

Published for Opposition

December 16, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 3, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 3, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 3, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 16, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 16, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 10, 2025 NONP
REFUSAL PROCESSED BY IB
Nov 30, 2025 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 14, 2025 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 8, 2025 RFCS
REFUSAL PROCESSED BY MPU
Nov 8, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 19, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 18, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 6, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 29, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 17, 2025 REPR